Progenics Acquires Molecular Insight Pharmaceuticals to Expand Oncology-Focused Pipeline

[at noodls] – – Gains Therapeutic and Diagnostic Compounds That Deepen Strategic Focus on PSMA Target – – Adds Late-Stage Ultra-Orphan Oncology Candidate – TARRYTOWN, N.Y., Jan. 22, 2013 (GLOBE NEWSWIRE) — Progenics … more

View todays social media effects on PGNX

View the latest stocks trending across Twitter. Click to view dashboard

See who Progenics is hiring next, click here to view